3 completed, 3 terminated, 1 unknown. 6 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 6 | Completed 3, Terminated 2, Unknown 1 |
Follow Medi-Tate Ltd.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Multi-center, International Prospective Follow up Study Review of medical history, administration of questionnaires, uroflowmetry and PVR as measured by ultrasound - Benign Prostatic Hyperplasia (BPH) | Terminated | Medi-Tate Ltd. | 17 | 2020-12-21 | 2021-04-29 | |
| A Prospective Study to Observe the Mechanism of Action of the MediTate iTind in Subjects With Symptomatic BPH With MRI ITind device implant - BPH | Not applicable | Terminated | Medi-Tate Ltd. | 1 | 2019-11-18 | 2021-10-07 |
| Study to Assess the Efficacy, Safety and Tolerability of (iTind) iTind - BPH | Not applicable | Terminated | Medi-Tate Ltd. | 5 | 2018-02-27 | 2020-07-22 |
| Study to Assess the Efficacy of the iTind in Subjects With Symptomatic BPH iTind - BPH | Not applicable | Unknown | Medi-Tate Ltd. | 149 | 2018-02-18 | 2023-10-23 |
| Pivotal Study to Assess the Safety and Effectiveness of the iTind Device iTIND, Sham Arm - Benign Prostate Hyperplasia | Not applicable | Completed | Medi-Tate Ltd. | 185 | 2015-07-01 | 2022-02-28 |
| Study to Assess the Efficacy of Medi-Tate iTind Device TIND System - Benign Prostatic Hyperplasia (BPH) | Not applicable | Completed | Medi-Tate Ltd. | 81 | 2014-10-01 | 2022-04-11 |
| Assessing Safety & Efficacy of MediTate Temporary Implant in Subjects With Benign Prostate Hyperplasia Insertion of Temporary Implantable Nitinol Device (TIND) - Bladder Neck Obstruction, Benign Prostate Hyperplasia | Not applicable | Completed | Medi-Tate Ltd. | 32 | 2011-09-01 | 2018-12-21 |
Prostatic Hyperplasia (4) · Urinary Bladder Neck Obstruction (1)
Canada (2) · Germany (2) · Italy (2) · Spain (2) · Switzerland (2) · United Kingdom (2) · United States (2) · Australia (1) · Belgium (1) · France (1) · Israel (1)
Claude Schulman, MD (1) · Francesco Porpiglia, MD (1) · Gordon Muir, MD (1) · Roy Farfara, MD (1) · Sheldon Pike, MD (1) · Thomas Bschleipfer, Prof. (1)